COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($) $ in Millions |
6 Months Ended | |
|---|---|---|
Jul. 13, 2021 |
Jun. 30, 2021 |
|
| REGENXBIO [Member] | ||
| Product Liability Contingency [Line Items] | ||
| Due remains value | $ 28.0 | $ 28.0 |
| Litigation Settlement, Amount Awarded from Other Party | 18.0 | |
| RDEB Product [Member] | ||
| Product Liability Contingency [Line Items] | ||
| Debt Instrument, Periodic Payment, Principal | 28.0 | |
| Debt Instrument, Increase, Accrued Interest | $ 6.4 |
| X | ||||||||||
- Definition Due remains value. No definition available.
|
| X | ||||||||||
- Definition Increase for accrued, but unpaid interest on the debt instrument for the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of the required periodic payments applied to principal. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount awarded from other party in judgment or settlement of litigation. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|